专家论坛(Specialist Forum)

甲状腺癌靶向研究的热点与展望

Published at: 2015年第24卷第5期

殷德涛 1 , 雷梦园 1
1 郑州大学第一附属医院 甲状腺外科,河南 郑州 450052
通讯作者 德涛 殷 Email: detaoyin@zzu.edu.cn
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2015.05.001
基金:
国家自然科学基金资助项目 81372863
郑州市科技领军人才资助项目 131PLJRC676

摘要

甲状腺癌是常见的内分泌肿瘤。近年来,甲状腺癌分子生物学研究取得显著的进展,而靶向治疗方面的研究将为甲状腺癌治疗提供新思路。笔者将分别从甲状腺癌干细胞、miRNA、甲状腺肿瘤微环境等方面对甲状腺癌的靶向研究进行阐述。


Advances of targeted therapy in thyroid carcinomas

Abstract

Thyroid cancer is a common endocrine tumor. In recent years, several advances have been made in the field of molecular biology and tumorigenic mechanisms of thyroid carcinomas, and targeted therapy research will provide new ideas for treating thyroid carcinoma. In this paper, the authors address the research progress of targeted therapy for thyroid carcinomas and includes the aspects of thyroid carcinoma stem cells, miRNA, and the microenvironment of thyroid cancer.


comments powered by Disqus

全文

引用

引用本文: 德涛 殷, 梦园 雷. 甲状腺癌靶向研究的热点与展望[J]. 中国普通外科杂志, 2015, 24(5): 623-626.
Cite this article as: YIN Detao, LEI Mengyuan . Advances of targeted therapy in thyroid carcinomas[J]. Chin J Gen Surg, 2015, 24(5): 623-626.